Table 1.

Histological subtypes (top panel) and the gender distribution of the histological subtypes (bottom panel) of the study cohort.

Mucoepidermoid Carcinoma	20.98%
Adenoid cystic carcinoma	17.74%
Acinic cell carcinoma	12.90%
Adenocarcinoma, not otherwise specified (NOS)	9.68%
Salivary duct carcinoma	9.68%
Undifferentiated carcinoma	6.45%
Carcinoma ex pleiomorphic adenoma	4.84%
Mammary analogue secretory carcinoma (MASC)	4.84%
Myoepithelial carcinoma	4.84%
Squamous cell carcinoma	3.23%
Adenosquamous carcinoma	1.61%
Carcinosarcoma	1.61%
Cribriform cystadenocarcinoma	1.61%